Behavioral Changes of Chronic Schizophrenic Patients Given L-5-Hydroxytryptophan
- 22 September 1972
- journal article
- clinical trial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 177 (4054), 1124-1126
- https://doi.org/10.1126/science.177.4054.1124
Abstract
Oral administration of the serotonin precursor L-5-hydroxytryptophan with a peripheral decarboxylase inhibitor produced Mild to moderate improvement in six of seven chronic undifferentiated schizophrenic patients who were resistant to phenothiazine treatment, as compared to an oral administration of a placebo. Two of four chronic paranoid schizophrenic patients who were resistant to phenothiazine treatment became worse with 5-hydroxytryptophan, one improved. It is presumed that these psychological changes were directly or indirectly produced from increases in brain serotonin. Indirect data from animals and humans indicate that there may be an abnormality in serotonin metabolism in some schizophrenics. While our data are consistent with this hypothesis, other explanations for our data must be entertained.Keywords
This publication has 6 references indexed in Scilit:
- Psychotomimetic N -Methylated Tryptamines: Formation in Brain in vivo and in vitroScience, 1972
- The Mechanism of Action of Hallucinogenic Drugs On A Possible Serotonin Receptor In The BrainInternational Review of Neurobiology, 1970
- A Fourteen-Symptom Behavior and Mood Rating Scale for Longitudinal Patient Evaluation by NursesPsychological Reports, 1968
- THE EFFECTS OF PRECURSOR LOADING IN THE CEREBRAL METABOLISM OF 5‐HYDROXYINDOLESJournal of Neurochemistry, 1968
- Inhibition of Serotonin Synthesis by Para-Chlorophenylalanine in Patients with the Carcinoid SyndromeNew England Journal of Medicine, 1967
- The 5-HydroxyindolesAdvances in Clinical Chemistry, 1958